A phase 3 clinical trial led at UCLA by Dr. April Armstrong helped show that the once-daily oral medication icotrokinra is a safe, effective alternative to injectable therapies for moderate to severe psoriasis. Read the full story: uclahs.fyi/4hZPOEx
A phase 3 clinical trial led at UCLA by Dr. April Armstrong helped show that the once-daily oral medication icotrokinra is a safe, effective alternative to injectable therapies for moderate to severe psoriasis. Read the full story: uclahs.fyi/4hZPOEx
The department of medicine and our community partners from across Los Angeles came together for the first-ever DoM LA Summit — a day to share stories, celebrate impact and spark new collaborations. Learn more: uclahs.fyi/47HGAsJ
The department of medicine and our community partners from across Los Angeles came together for the first-ever DoM LA Summit — a day to share stories, celebrate impact and spark new collaborations. Learn more: uclahs.fyi/47HGAsJ
Learn how she's rethinking vaccine design here: uclahs.fyi/3VZOOWG
Learn how she's rethinking vaccine design here: uclahs.fyi/3VZOOWG
Watch highlights from the day and check out some standout posters here: uclahs.fyi/3WFgfFi
Watch highlights from the day and check out some standout posters here: uclahs.fyi/3WFgfFi